Global Transurethral Prostatic Resection Device Market Growth (Status and Outlook) 2025-2031

The global Transurethral Prostatic Resection Device market size is predicted to grow from US$ 1383 million in 2025 to US$ 1895 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

A transurethral resection of the prostate (TURP) is a surgical procedure that involves cutting away a section of the prostate. The prostate is a small gland in the pelvis only found in men. It"s located between the penis and bladder, and surrounds the urethra (the tube that carries urine from the bladder to the penis).

The global transurethral prostatic resection device market refers to the industry that provides medical devices used in transurethral resection of the prostate (TURP) procedures. TURP is a minimally invasive surgical procedure performed to treat benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland. Here’s an overview of the market:

Market Overview: The transurethral prostatic resection device market has witnessed significant growth due to the increasing prevalence of BPH and the rising demand for minimally invasive treatment options. TURP is a widely accepted and effective procedure for relieving urinary symptoms associated with BPH, and the demand for TURP devices is driven by the growing patient population and advancements in technology.

Procedure and Device: TURP involves the removal of excess prostate tissue using a resectoscope, which is a specialized instrument inserted through the urethra. The resectoscope typically consists of a sheath, a working element with an electrode, and an irrigation system. During the procedure, the resectoscope allows the surgeon to remove the obstructing prostate tissue and cauterize bleeding vessels.

Types of TURP Devices: The market offers a variety of TURP devices, including monopolar and bipolar resectoscopes. Monopolar resectoscopes use an electrical current to cut and cauterize tissue, while bipolar resectoscopes pass the electrical current through the saline irrigation fluid, reducing the risk of complications associated with monopolar devices. Other types of TURP devices may include continuous flow resectoscopes and laser resectoscopes, which offer alternative methods for performing the procedure.

Market Players: The market for transurethral prostatic resection devices is competitive and comprises various medical device manufacturers. Key market players may include leading medical technology companies and specialized manufacturers that provide a range of TURP devices. These companies focus on product innovation, safety, and efficiency to meet the needs of healthcare professionals performing TURP procedures.

Market Dynamics: The market is driven by factors such as the increasing prevalence of BPH, technological advancements in TURP devices, a growing elderly population, and the demand for minimally invasive procedures. Additionally, rising awareness about the benefits of TURP over traditional open surgeries, such as shorter hospital stays and faster recovery, contributes to the market growth.

Regional Markets: The global transurethral prostatic resection device market is segmented into various regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe have a significant market share due to the high prevalence of BPH and the availability of advanced healthcare facilities. The market in Asia Pacific is expected to witness substantial growth due to the increasing aging population and improving healthcare infrastructure in the region.

Regulatory Landscape: The transurethral prostatic resection device market is subject to various regulatory and quality standards set by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Manufacturers must comply with these regulations to ensure the safety and effectiveness of their devices.

Market Outlook: The global transurethral prostatic resection device market is projected to grow in the coming years, driven by the increasing prevalence of BPH, advancements in TURP technology, and the growing adoption of minimally invasive procedures. However, factors such as the availability of alternative treatment options and the high cost of TURP devices may pose challenges to market growth.

LPI (LP Information)' newest research report, the “Transurethral Prostatic Resection Device Industry Forecast” looks at past sales and reviews total world Transurethral Prostatic Resection Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Transurethral Prostatic Resection Device sales for 2025 through 2031. With Transurethral Prostatic Resection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transurethral Prostatic Resection Device industry.

This Insight Report provides a comprehensive analysis of the global Transurethral Prostatic Resection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transurethral Prostatic Resection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transurethral Prostatic Resection Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transurethral Prostatic Resection Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transurethral Prostatic Resection Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Transurethral Prostatic Resection Device market by product type, application, key players and key regions and countries.

Segmentation by Type:

Monopolar TURP

Bipolar TURP

Segmentation by Application:

Benign Prostate Hyperplasia

Urinary Tract Infection

Erectile Dysfunction

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Wellspect HealthCare

Manfred Sauer

Teleflex

Hollister

Boston Scientific

Karl Storz

Olympus

Lumenis

Covidien

Cook Medical

Please note: The report will take approximately 2 business days to prepare and deliver.